{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Title: Carotid Occlusion Surgery Study: A Randomised Controlled Trial"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "COSS was a parallel group, prospective, 1:1 randomised, open-label, blinded-adjudication trial."
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants with angiographic confirmed complete ICA occlusion causing TIA or ischemic stroke within 120 days and hemodynamic cerebral ischemia (elevated OEF by PET) were randomised to surgical or medical treatment."
      },
      "Intervention": {
        "score": 2,
        "evidence": "The surgical group underwent STA-MCA cortical branch anastomosis."
      },
      "Objective": {
        "score": 1,
        "evidence": "The Carotid Occlusion Surgery Study (COSS) was conducted to determine if STA-MCA bypass, when added to best medical therapy, would reduce subsequent ipsilateral stroke in patients with complete ICA occlusion and elevated OEF."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the rate of ipsilateral stroke over two years."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was conducted centrally, and outcome assessors were blinded."
      },
      "Blinding": {
        "score": 2,
        "evidence": "open-label, blinded-adjudication trial."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 195 patients were randomised: 97 to surgery and 98 to medical therapy."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "In the intention-to-treat analysis, the two-year primary endpoint rates were 21.0% for the surgical group and 22.7% for the medical group (p=0.78)."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "the two-year primary endpoint rates were 21.0% for the surgical group and 22.7% for the medical group (p=0.78)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Fourteen (15%) of 93 surgical patients experienced an ipsilateral hemispheric stroke within 30 days post-operation, with 12 occurring within two days."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: [Trial registration number]"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: [Source of funding]"
      }
    },
    "total_score": 18,
    "max_score": 25
  },
  "model": "gpt-4o"
}